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ABSTRACT
Signal Transducers and Activators of Transcription
(STAT) 5A/B regulate cytokine-inducible genes upon
binding to GAS motifs. It is not known what per-
centage of genes with GAS motifs bind to and are
regulated by STAT5. Moreover, it is not clear
whether genome-wide STAT5 binding is modulated
by its concentration. To clarify these issues we
established genome-wide STAT5 binding upon
growth hormone (GH) stimulation of wild-type (WT)
mouse embryonic fibroblasts (MEFs) and MEFs
overexpressing STAT5A more than 20-fold. Upon
GH stimulation, 23827 and 111939 STAT5A binding
sites were detected in WT and STAT5A over-
expressing MEFs, respectively. 13278 and 71561
peaks contained at least one GAS motif. 1586 and
8613 binding sites were located within 2.5kb of
promoter sequences, respectively. Stringent filter-
ing revealed 78 genes in which the promoter/
upstream region ( 10kb to+0.5kb) was recognized
by STAT5 both in WT and STAT5 overexpressing
MEFs and 347 genes that bound STAT5 only in
overexpressing cells. Genome-wide expression
analyses identified that the majority of STAT5-
bound genes was not under GH control. Up to 40%
of STAT5-bound genes were not expressed. For
the first time we demonstrate the magnitude of
opportunistic genomic STAT5 binding that does
not translate into transcriptional activation of neigh-
boring genes.
INTRODUCTION
Signal transducers and activators of transcription (STAT)
5A and 5B (referred to as STAT5) are latent transcription
factors that are activated by cytokines, such as interleu-
kins, erythropoietin, thrombopoietin, growth hormone
(GH) and prolactin, through their respective receptors
(1). Mice, from which the Stat5 genes had been deleted
globally or in deﬁned cell populations have shed light onto
general and cell-speciﬁc functions. These include erythro-
poiesis, immune functions, liver metabolism, body growth
and mammary gland development during pregnancy
(2–10). In addition, humans carrying homozygous muta-
tions in the Stat5B gene are characterized by growth
defects, due to impaired IGF1 signaling and immune
defects (11). STAT5 levels vary greatly between tissues
and evidence is mounting that distinct levels are needed
for different cellular functions (12). In turn, excessive ac-
tivation of STAT5 has been linked to the progression of
solid tumors and leukemia (13,14).
Genes containing GAS motifs (consensus sequence
TTCnnnGAA) bound in vivo by STAT5 and whose ex-
pression is STAT5-dependent are considered direct
STAT5 targets. Gene expression studies on cells
ectopically overexpressing STAT5 (15) and siRNA-
mediated reduction of STAT5 (16) have been employed
in the identiﬁcation of putative target genes. Last, com-
parative gene expression analyses of wild-type (WT) and
*To whom correspondence should be addressed. Tel: +1 301 496 217; Fax: +1 301 480 7312; Email: lotharh@mail.nih.gov
Published online 8 February 2012 Nucleic Acids Research, 2012, Vol. 40, No. 10 4461–4472
doi:10.1093/nar/gks056
Published by Oxford University Press 2012.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.STAT5-null cells and tissues have provided additional
candidate target genes (17). In many cases, GAS motifs
were detected within regulatory regions of these putative
STAT5 target genes. However, due to the experimental
design of these studies, it is not necessarily possible to
distinguish between bona ﬁde STAT5 target genes and
genes whose induction is secondary to the STAT5 signal-
ing pathway. Excessive STAT5 activation has been
observed in various tumor cells and a case has been
made that this occurs through the aberrant activation of
STAT5 target genes (18). However, there is little experi-
mental evidence to suggest that elevated STAT5 levels and
activity are able to control otherwise dormant STAT5
targets genes in vivo.
Here, we have addressed two questions pertaining to
STAT5 as a cytokine-controlled DNA binding protein
and transcriptional activator. First, we determined
GH-induced genome-wide binding of STAT5 and asked
to what extent a 20-fold elevated concentration of STAT5
affects its binding pattern. Second, we asked to what
extent the genes that bind STAT5 are controlled by
STAT5 and GH. For this purpose, we have established
a well controlled experimental system that permitted
qualitative and quantitative analyses of STAT5 binding
and corresponding transcriptional consequences. We
have used mouse embryonic ﬁbroblasts (MEFs) with
three distinct genotypes; WT, Stat5
 /  and Stat5
 / 
ectopically expressing STAT5A at a more than 20-fold
elevated concentration. ChIP-seq experiments were used
to identify genomic loci that bind STAT5 at normal
and elevated concentrations upon GH stimulation.
Subsequently, we analyzed the corresponding gene expres-
sion. This approach allowed us to address the following
questions: (i) How many genomic loci bind STAT5 in the
presence of GH? (ii) Does a greatly elevated STAT5A
concentration alter STAT5 binding quality and quantity?
(iii) Does STAT5 binding correlate with GH-dependent
and independent transcription of neighboring genes?
MATERIALS AND METHODS
Mice, isolation of cells and cell culture
Mice were handled and housed in accordance with the
guidelines of National Institute of Diabetes, Digestive
and Kidney Diseases (NIDDK) Animal Care and Use
Committee. Stat5
+/  mice (2) were bred into the C57BL/
6 background. Stat5
+/  mice were intercrossed and MEFs
were isolated from 12.5–13.5-day fetuses. MEFs were
expanded in DMEM with high glucose supplements and
15% fetal bovine serum (FBS). MEFs of passage 9–10
were used for experiments. After 5h of starvation in
serum-free medium with 0.1% of BSA, MEFs were
treated with growth hormone for indicated time period.
Retroviral infection
The retroviral-expression vector carrying a WT Stat5A
gene was based on an MSCV-IRES-GFP backbone (gift
from Richard Moriggl, Ludwig-Boltzmann Institute,
Vienna, Austria). 293T cells were transfected with the
plasmid using FuGENE (Roche, Indianapolis, IN,
USA). Supernatants were collected for 48–72h after
transfection and passed through a 0.45-mm ﬁlter before
freezing at  80 C. For the infection, 10
6 Stat5
 /  MEFs
were seeded on a 10-cm culture dish and infected the next
day with retrovirus in the presence of 8mg/ml polybrene.
After infection, non-ﬂuorescent cells and GFP-expressing
cells were isolated using BD FACS Vantage Cell Sorter
Flow Cytometer (Becton Dickinson, San Jose, CA, USA)
and sorted directly into PBS. Sorted MEFs were main-
tained in Dulbecco’s Modiﬁed Eagle medium (DMEM)
supplemented as described above.
Western blots
After 5h starvation followed by 45min stimulation with
GH, protein was extracted from primary Stat5
+/+ MEFs
and Stat5
 /  MEFs overexpressing Stat5A. In total, 1 
10
6 cells were pelleted by centrifuging for 1min at 1500g
and then washed once with ice-cold PBS. Cells were lysed
by adding lysis buffer containing: 50mM Tris pH 7.4,
150mM NaCl, 10% glycerol, 1% IGEPAL (NP-40),
2mM EDTA, 100mM NaF and protease inhibitor
cocktail (Roche) and incubating for 30min on ice.
Lysates were cleared by centrifugation in at 4 Ci na
microfuge at maximum speed. Protein concentration was
determined by Bradford reagent (Bio-Rad, Richmond,
CA, USA). A quantity of 10mg of total protein was
electrophoretically separated and transferred to
polyvinylidene ﬂuoride (PVDF) membranes using the
NuPAGE system (Invitrogen, Carlsbad, CA, USA).
Membranes were probed with anti-STAT5 (C-17),
anti-STAT3 (C-20) and anti-beta actin antibodies (C-4)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
phospho-STAT5 (Y694) antibody from Cell Signaling
Technology (Danvers, MA, USA) and HRP-conjugated
secondary antibodies (GE Healthcare, Wauwatosa, WI,
USA). Proteins were detected using enhanced chemilumin-
escence substrate (Pierce, Rockford, IL, USA), Kodak
MR ﬁlm (Kodak, Rochester, NY, USA) and Amersham
Hyperﬁlm ECL (GE Healthcare, Wauwatosa, WI, USA).
RNA isolation and quantitative real-time PCR analysis
After 5h of starvation, MEFs were cultured for 2h in the
absence or presence of GH and total RNA was isolated
using RNeasy mini kit (Qiagen, Valencia, CA, USA).
A quantity of 1mg amounts of RNA were reverse
transcribed (cDNA reverse transcription kit; Applied
Biosystems, Foster City, CA, USA). Real-time quantiﬁca-
tion of mRNA transcript levels was performed using the
TaqMan gene Expression Master Mix (Applied
Biosystems, Foster City, CA, USA) according to the
manufacturer’s instructions. Real-time PCR was carried
out using an ABI Prism 7900HT (Applied Biosystems,
Foster City, CA, USA). TaqMan probes for STAT5a
(Mm00839861_m1), Socs1 (Mm00782550_s1), Socs2
(Mm00850544_g1), Bcl6 (Mm00477633_m1) and
beta-actin (4352341E) were used (Applied Biosystems,
Foster City, CA, USA) for Real-time PCR.
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After 5h of starvation, cells were treated for 2h with GH.
Total cellular RNA from each group of the MEFs was
extracted with TRIzol reagent (Invitrogen) according to
the manufacturer’s instructions. Microarray analyses were
performed using Affymetrix Mouse Genome 430 2.0
GeneChips (Affymetrix, Santa Clara, CA, USA) (four
groups, biological triplicates for each group). Expression
values were determined with GeneChip Operating
Software (GCOS) v1.1.1 software. Robust Multichip
Average (RMA) signals were summarized using
GeneSpring GX 10.0.1 (Agilent) and normalized by
quantile normalization. All data analysis was performed
with GeneSpring software GX 10.01.
Chromatin immunoprecipitation coupled by illumina
sequencing
Chromatin immunoprecipitation coupled by illumina
sequencing (ChIP-seq) experiments were performed as
described previously (19,20). In brief, after 5-h starvation,
WT, Stat5
 / , or STAT5A-Stat5
 /  MEFs were
stimulated with or without 1mg/ml GH for 45min.
MEFs were then cross-linked with 1% formaldehyde for
10min. Chromatin from 5 10
6 cells was used for each
ChIP experiment. Antibodies against STAT5 (sc-835,
Santa Cruz, CA, USA) and IgG (AB-105C, R&D
System) were used. The ChIP DNA fragments were
blunt-ended, ligated to the Solexa paired-end adaptors
and sequenced with the Illumina Hi-seq 2000 genome
analyzer.
ChIP-seq data analysis
Experimental data sets came from WT (WT-GH),
Stat5
 /  (KO-GH) and Stat5
 /  overexpressing
STAT5A (OE-GH) MEFs upon GH stimulation. The
mapped tags of STAT5 antibodies and IgG samples
were analyzed using the MACS program (21) with the
following parameters; -mfold=10,20 (fold enrichment
threshold for the detection of highly enriched regions) -g
mm (mouse genome) –p 1.0e 4( P-value cut-off). The
identiﬁed peaks were further split by using PeakSplitter
(22). ChIP-seq data obtained from GH-treated Stat5
 / 
MEFs (Transfected with an empty vector,
KO-empty-GH) served as negative controls and were in-
dependently processed with the same parameters. A total
of 28343 (WT-GH), 117,771 (OE-GH), 38,451 (KO-GH)
and 23,404 (KO-empty -GH) peaks were identiﬁed. Since
the identiﬁed STAT5 binding peaks obtained in Stat5
 / 
MEFs (KO-GH and KO-empty-GH) should be
false-positives; we only used those peaks that did not
overlap with those of the KO sets. With this approach, a
total of 23827 and 111939 STAT5 peaks were identiﬁed in
the WT-GH and OE-GH sets, respectively. STAT5 binds
to DNA directly and its DNA binding motif (GAS motif)
has been well deﬁned. We utilized the GAS motif infor-
mation to accurately identify bona ﬁde STAT5 binding
sites. The Find Individual Motif Occurrences (FIMO)
DNA motif identiﬁcation tool (23) was used to scan the
peak regions with a STAT5 position-speciﬁc scoring
matrix (P-value threshold: 1e 3). Out of the 23827 and
111939 STAT5 peaks, 13278 and 71561 peaks contained
at least one GAS motif within their peak regions. These
ﬁnal peaks were regarded as bona ﬁde STAT5 binding sites
and used in this study. For the comparison analysis
(Figures 3 and 4), the total number of tags was normalized
to 10 million.
Gene classiﬁcation
Genes were classiﬁed based on the quantity of STAT5
binding within a 2.5kb promoter region and/or adjacent
8kb of upstream region. STAT5 binding within each pro-
moter region was measured by means of the maximum
peak height, as well as the sum of peak heights. The
maximum peak height (max_peak_height) indicates
STAT5 afﬁnity to target sites, whereas the sum of peak
heights represents the overall amount of STAT5 binding.
The sum of peak heights was converted to z-score for
comparison (z-score_sum). To identify bona ﬁde STAT5
target genes, the following peaks were deﬁned as strong
(or weak) peaks; either max_peak_height  95th percentile
(70th for weak) among the heights of identiﬁed peaks or
z-score_sum 5. With the deﬁned peaks, genes were clas-
siﬁed as follows; class I—genes with STAT5 bindings in
both WT-GH and OE-GH promoter regions, class II—
genes with STAT5 bindings only in OE-GH promoter
region, class III—genes with STAT5 bindings in both
WT-GH and OE-GH upstream regions and class IV—
genes with STAT5 bindings only in OE-GH upstream
region. With the strong peaks, 29, 161, 49 and 186 genes
were categorized into class I, II, III and IV, respectively.
RESULTS
STAT5A overexpression in MEFs
WT, Stat5
 /  and Stat5
 /  MEFs overexpressing mouse
STAT5A (Stat5
 / ; Stat5A) MEFs were prepared (see
‘Materials and Methods’ section). The Stat5a mRNA con-
centration in Stat5
 / ; Stat5A MEFs was more than
100-fold higher than in control cells (Figure 1A). The
STAT5A protein level in Stat5
 / ; Stat5A MEFs was at
least 20-fold higher than in control MEFs (Figure 1B).
Similarly, greatly elevated p-STAT5 levels were observed
in Stat5
 / ; Stat5A MEFs (Figure 1B) upon GH stimula-
tion. This demonstrates that neither the GH receptor nor
JAK2 were limiting in this system and that the elevated
STAT5 levels could be activated.
Genome-wide in vivo mapping of STAT5A binding sites
To identify genetic loci readily recognized by
activated STAT5 in vivo, we used ChIP-seq to analyze
WT Stat5
 /  (WT-GH) and STAT5A overexpressing
Stat5
 / ; Stat5A MEFs (OE-GH) upon GH stimulation.
Stat5
 /  MEFs and rabbit serum IgG served as negative
controls. Control and experimental MEFs were grown to
 70% conﬂuency, starved for 5h, followed by GH stimu-
lation for 45min and ChIP-seq analysis (see ‘Materials
and Methods’ section).
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of the WT-GH and OE-GH samples were processed with
corresponding IgG controls by using a peak-calling
program, MACS (see ‘Materials and Methods’ section
for details) (21). A total of 28343 and 117771 regions
were initially identiﬁed in the WT-GH and OE-GH sets,
respectively. Subsequently, regions overlapping with
STAT5 enriched sites in the Stat5
 /  MEFs samples
were discarded. We pinpointed GAS motifs within the
binding regions using the FIMO motif identiﬁcation tool
(23) and deﬁned peaks containing at least one GAS motif
as bona ﬁde STAT5 binding sites. These high quality peaks
were used throughout this study. In sum, 13278 and
71561 STAT5 peaks were regarded as bona ﬁde STAT5
binding sites in WT-GH and OE-GH MEFs, respectively
(Figure 2). In total, 4690 peaks were shared between the
two data sets and 66871 were de novo sites (Figure 2A).
To further identify bona ﬁde STAT5 target genes, we
focused on peaks located within 2.5kb of promoter se-
quences ( 2kb to +0.5kb) or upstream sequences ( 10
kb to  2kb). Based on the max_peak_height we called
strong (95th percentile) and weak (70th percentile) peaks
(see ‘Materials and Methods’ section). Using these criteria
we deﬁned four classes of genes; class I—genes with
STAT5 binding in their promoters in both WT-GH and
OE-GH MEFs; class II—genes with STAT5 binding in
their promoters only in OE-GH MEFs; class III—genes
with STAT5 binding in upstream regions in both WT-GH
and OE-GH MEFs; class IV—genes with STAT5 binding
in upstream regions only in OE-GH MEFs. Based on
Figure 2. Comparison of genome-wide STAT5 binding in WT and STAT5A overexpressing MEFs. (A) Venn diagrams illustrate common and
unique STAT5 binding sites between two different cell-contexts. The number of STAT5 target genes was calculated according to strong and weak
criteria (see ‘Materials and Methods’ section). (B) STAT5 binding was quantiﬁed. Fold changes (antibody/IgG) around peak summits (±5kb) were
standardized in each group using z-score. Bar graphs in the right panel show actual fold changes at the peak summit and a region 4kb away from the
peak summit.
Figure 1. Analysis of WT and STAT5A overexpressing MEFs. Stat5
+/+ and Stat5
 /  MEFs over expressing retrovirally transduced STAT5A
(Stat5
 / ; Stat5A) were analyzed upon starvation and GH induction. (A) qPCR of mRNA isolated from control and transgenic MEFs in the
absence and presence of GH. (B) western blot.
4464 Nucleic Acids Research, 2012,Vol.40, No. 10strong peaks, 29, 161, 49 and 186 genes were categorized
into class I, II, III and IV, respectively (Figure 2A). In
general, STAT5 binding to promoter regions ( 2kb to
+0.5kb) was much stronger than binding to upstream se-
quences ( 10 kb to  2kb). In addition, we quantiﬁed the
level of STAT5 bindings in each group using z-score.
Comparison analysis reveals that the level of STAT5
binding is changed according to the context of cells.
For example, 8588 STAT5 binding sites show very weak
STAT5 binding (or not bound by STAT5) in the OE-GH
context in terms of the fold change (Figure 2B) although
these two cells were grown in very similar conditions
except with the dosage of STAT5.
Class I: STAT5 binding to promoter regions independent of
STAT5 concentration. Using strong and weak criteria,
STAT5 bound to promoter sequences of 29 and 214
genes, respectively (Supplementary Table S1). The class
of 29 genes encompassed bona ﬁde STAT5 target genes,
including Socs2, Socs3, Cish and Bcl6 (Figure 3 and
Table 1). Overall, both the maximum peak height and
the peak sum were similar or slightly higher in STAT5A
overexpressing cells compared with WT MEFs (Table 1).
In general, STAT5 binding was observed only in the
presence of GH.
Although higher STAT5A concentrations did not sig-
niﬁcantly alter binding at GAS motifs recognized already
in WT MEFs, de novo binding to juxtaposed GAS motifs
within a given gene was observed in several cases. For
example, while promoter-bound GAS motifs in the Bcl6
gene were recognized by STAT5 independent of its con-
centration, a subset of intronic GAS sites was recognized
only upon STAT5A overexpression (Figure 4). The 12 kb
Bcl6 locus contains 20 GAS motifs within the STAT5
binding areas, 13 of which are conserved between mouse
and opossum. Under physiological STAT5 concentra-
tions, ﬁve conserved GAS motifs within the promoter
region were occupied. De novo occupancy of a set of
four highly conserved GAS motifs within the ﬁrst intron
but not other conserved GAS motifs was obtained at
elevated STAT5 concentration (Figure 4). Within the
Cish locus, de novo binding was observed over ﬁve
conserved GAS motifs within the 30 ﬂanking region,
although the degree of binding over promoter-bound
GAS motifs remained unchanged (Figure 3). Similarly,
elevated STAT5A levels led to the occupation of de novo
binding sites within the promoter upstream region of the
Socs3 gene (Figure 4). The two distal ones are highly
conserved between species.
Based on global gene expression analyses of these 29
genes, all 26 represented on the array were expressed.
Expression ranged over 40-fold between the lowest (Irf2)
and highest (Ubc) (Table 1). However, expression of only
four genes (Socs2, Socs3, Cish and Bcl6) was under
GH-STAT5 control in WT MEFs (Table 1). At 20-fold
elevated STAT5 concentration, one additional gene (Tle1)
entered this category (Table 1). Whereas GH-induced ex-
pression of the Socs3 and Bcl6 genes was not altered by
extra STAT5A, Socs2 and Cish mRNA levels increased
(Table 1). Expression of selected genes was veriﬁed using
RT–PCR (Supplementary Figure S1). These data demon-
strate that in WT cells, GH-induced STAT5 binding to
promoter sequences coincides only for some genes with
GH-induced expression and STAT5 dependency.
Class II: STAT5 binding to promoter regions only at
elevated STAT5A concentration. Using strong and weak
criteria, STAT5 bound to promoter sequences of 161 and
1551 genes, respectively (Supplementary Table S1). Genes
in this group, which includes Esr1 and Rwdd1, exhibit
STAT5 binding only in STAT5 overexpressing MEFs
(OE-GH). Out of the 161 genes, 135 were represented by
probes on the Affymetrix arrays. Out of the 135 genes, 18
were not expressed at detectable levels (Table 2). Among
those that were expressed, mRNA levels ranged over
30-fold between genes. Using a 2-fold cut-off, only the
Esr1 gene had acquired STAT5-dependent GH-induction
in STAT5A overexpressing MEFs (Table 2). These results
demonstrate that elevated STAT5 levels produce de novo
STAT5 binding to genes that are not targeted at lower
Figure 3. Examples of STAT5 target genes. ChIP-seq analysis pinpoints STAT5 binding sites within the 2.5kb of promoter regions of the Wap,
Socs2, Cish, Rwdd1 and Aebp2 genes in WT (WT-GH) and STAT5 overexpressing (OE-GH) MEFs stimulated with GH. STAT5 binding patterns in
STAT5 overexpressing MEF (OE-WT, no GH) are shown as negative control. Horizontal bars indicate genes and small vertical bars show locations
of GAS motifs.
Nucleic Acids Research, 2012,Vol.40, No. 10 4465Table 1. STAT5 binding and expression proﬁle in Class I genes (STAT5 binding in promoters regions in both WT-GH and OE-GH MEFs)
Name Max_peak_height Gene expression
WT-GH WT-GH OE-GH OE-GH WT WT-GH OE OE-GH
Upstream Promoter Upstream Promoter
Cish 0 149.3 27.2 120.7 148 695 <100 1217
Mvd 0 39.9 0 119.1 1690 1866 1213 1664
Serpinh1 0 56.1 44.4 101.4 7166 6290 5498 5565
Plec 34.9 75.6 27.7 96.7 6450 7335 7300 7900
Socs3 0 92.8 71.6 83.6 738 1375 255 1097
Fn1 22.4 35.3 14.6 79.9 10073 9805 10399 10814
Ubc 22.6 26.5 11.5 79.9 11967 11706 12006 12847
Psmd3 0 68.5 0 76.8 1179 1256 1264 1253
Nckap5 19.8 47.9 0 71.6 na
Irf2 0 34.9 48.6 69.5 214 221 269 308
Slc25a37 0 45.3 0 66.4 625 739 817 1062
Bcl6 32.5 82 23.5 62.2 3032 1010 2463 1105
Ctgf 13 22.4 91.4 61.7 7518 7162 6891 8105
Rhoq 0 29.9 0 60.6 5172 4481 3701 3924
Gm8580 0 43.1 6.8 58 na
Gm4262 0 40.1 0 57 na
Gclm 0 24.1 0 57 473 559 414 509
Nacc2 0 32.1 15.7 55.9 1359 1285 2211 1926
Poli 0 41.9 7.3 53.3 232 172 425 473
Plekhg2 32.3 34.9 59.6 52.8 2484 3112 2950 4847
Ergic2 0 22.2 6.3 49.6 1018 1138 1170 1191
Ppm1k 0 57.5 0 49.1 425 235 314 412
Cyp1b1 0 46.7 0 48.6 9005 8340 5645 4382
Katnb1 0 59.5 0 47.5 133 186 229 344
Ugp2 0 50.5 10.5 44.9 3319 3138 4230 5644
Flot1 0 69.7 7.8 39.2 3591 3242 5209 5803
Sgk1 46.1 48.5 15.2 34.5 4446 4030 7093 8139
Tle1 0 39.3 0 34.5 192 223 338 703
The peak height numbers refer to sequence tags and the gene expression numbers are relative expression levels provided by the Affymetrix software.
na, not available.
Figure 4. Browser images of Bcl6 and Socs3. The STAT5A overexpression upon GH induction causes additional binding to GAS motifs near the
promoter regions of Bcl6 and Socs3. Light red vertical bars indicate the STAT binding regions shared between WT (WT-GH) and STAT5
overexpressing (OE-GH) MEFs. Light blue vertical bars represent unique STAT binding sites shown only in OE-GH, but not in WT-GH. The
bottom panel depicts positions of GAS motifs, gene and peak summits, as well as conservation score (PhastCon score).
4466 Nucleic Acids Research, 2012,Vol.40, No. 10concentrations. However, this de novo binding does not
place these cells under STAT5-dependent GH control.
Moreover, 10% of the de novo recognized genes are silent.
Class III: STAT5 binding to gene upstream regions
independent of STAT5 concentration. STAT5 bound to
the upstream region ( 10kb to  2kb) of 49 genes both
in WT and STAT5A overexpressing cells. Out of the 39
genes with probes on the Affymetrix chips, 7 were not
expressed at detectable levels (Table 3). Two genes,
Sbno2 and Mapkapk3, acquired modest GH-inducibility
in GH overexpressing cells. Sbno2 belongs to a family of
helicase co-repressors and its expression is induced in
macrophages by IL-10 through STAT5 (24).
Class IV: STAT5 binding to gene upstream regions only
at elevated STAT5 concentration. Upon STAT5 over-
expression, de novo binding to the upstream region
( 10kb to  2kb) of 186 genes was observed (Table 4).
Out of the 158 genes represented on the microarray, ex-
pression of 41 was undetectable. Out of the 117 expressed
genes, 4 acquired a slightly <2-fold GH induction in
STAT5 overexpressing MEFs (Table 4).
A biological replicate ChIP-seq experiment with
STAT5A overexpressing MEFs in the absence and
presence of GH validated and substantiated the above
ﬁndings (Supplementary Figure S2). The pattern of
STAT5 binding peaks is very similar to the original one,
and we conﬁrmed the unique STAT5 binding sites (Figure
4) which are only observed in the OE-GH cell-context.
The MEME-ChIP program (25) successfully identiﬁed
the canonical STAT5 binding motif (TTC...GAA) as
the most frequently occurring sequence at the top 1000
STAT5 binding regions. Among the top 10000 peaks
identiﬁed in the replicate, 86% of the peaks overlapped
with peaks in the original data set.
Motif analysis
Approximately 60% of STAT5 binding is located over
GAS motifs, whereas in 40% of the binding areas no clas-
sical GAS motifs are found. The identiﬁed areas of
STAT5 binding were separated into two sets according
to the existence of GAS motif (canonical versus
non-canonical). De novo motif prediction (25) that uses
public motif databases for co-factor identiﬁcation (26) es-
tablished bona ﬁde GAS motifs in all peaks in STAT5
overexpressing MEFs (Supplementary Figure S3A). Peak
height in WT MEFs was in general lower and convincing
GAS motifs were found only in strong peaks. In search
for additional transcription factor binding motifs
co-localizing with GAS motifs, we identiﬁed AP1 motifs
in strong and intermediate peaks of STAT5 over-
expressing MEF (Supplementary Figure S3). No clear
Table 2. STAT5 binding and expression proﬁle in Class II genes (STAT5 binding in promoter regions only at elevated STAT5A concentration)
Name Max_peak_height Gene expression
WT-GH WT-GH OE-GH OE-GH WT WT-GH OE OE-GH
Upstream Promoter Upstream Promoter
Ncald 0 0 16.2 176.1 <100 <100 <100 130
Rbm25 0 0 0 117 na
Cr1l 0 0 0 99.8 1979 2253 2161 2377
Emp1 0 0 0 97.7 3718 3276 2154 2434
Rwdd1 0 0 0 97.2 3063 3358 3980 4549
Fzd7 0 0 31.9 94.1 2645 2367 2374 1965
Kpna1 0 0 0 90.4 2987 3190 2568 3110
Nedd9 0 0 0 89.9 2382 1812 2023 1480
Pan2 0 0 0 88.3 407 390 591 500
Aebp2 0 0 11.5 86.7 3546 4429 3870 4164
Ccl2 33.7 0 35 84.6 3744 13568 171 3522
Olfr1423 0 0 10.5 84.6 na
Opn5 11.8 0 5.7 84.6 na
Dse 0 0 44.4 84.1 3272 2816 3427 4141
Mkl1 0 0 0 82 1091 1276 2155 2538
Rbms1 0 0 0 81 6571 6109 5408 6081
Shq1 0 0 16.7 79.9 191 265 138 225
Ppp1r12b 0 0 18.3 77.3 392 687 <100 145
Phlda1 0 2.4 3.1 75.8 922 1477 477 646
Zfp36l1 0 0 49.1 75.8 2867 3316 3397 3604
Psmd4 0 0 0 74.7 783 1027 920 1224
Ntn4 0 0 0 72.6 <100 <100 <100 <100
Tnc 0 0 0 69.5 7822 9009 3884 4716
Dapk3 0 0 28.7 68.5 405 391 783 870
Aldh18a1 0 0 0 66.4 4119 3250 2654 2851
Esr1 0 0 0 60.1 190 151 237 552
Snai3 0 0 8.9 54.3 <100 <100 <100 <100
Pxk 0 0 10.5 48.6 537 531 385 562
1110054M08Rik 0 0 9.4 38.7 na
Mical1 0 0 0 28.2 2377 2538 4588 4862
The peak height numbers refer to sequence tags and the gene expression numbers are relative expression levels provided by the Affymetrix software.
na, not available.
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STAT5 binding areas.
Cell-speciﬁc STAT5 target genes
A number of cell-speciﬁc STAT5 target genes have been
reported. Among them are prolactin-induced milk protein
genes in mammary tissue (27–29), FoxP3 in Regulatory
T cells (Tregs) (10), Tbx21, Il4ra and Il17rb2 in T-cells
(ref) and IL17 in TH17 cells (30). Regardless of the
STAT5 concentration, no binding was observed to GAS
motifs in established regulatory regions of milk protein
genes, the IL17a and IL17f genes and the Tbx21 and
Il12rb2 genes that are activated by IL-2 through STAT5
in Th1 cells (30). Similarly, no binding was observed in the
Il4ra gene that is induced by IL-2 through STAT5 in
T-cells or the Foxp3 gene. These ﬁndings demonstrate
that STAT5 is unable to access GAS motifs within
genuine cell-speciﬁc STAT5 target genes even at very
high concentrations and levels of activation.
Correlation analysis between gene expression levels and
STAT5 binding
A total of nearly 900 genes in MEFs were induced more
than 2-fold by GH (Supplementary Table S2). For each
gene in the four classes, we established the correlation
between the extent of STAT5 binding and GH-induced
expression. Gene expression was estimated from micro-
array analysis (y-axis) and the degree of STAT5
bindings was calculated using maximum peak height in
either promoter or upstream regions according to the clas-
siﬁcation (x-axis) (see ‘Materials and Methods’ section).
Correlation was measured with Pearson’s correlation co-
efﬁcient. Each spot indicates a single gene. As shown in
Figure 5, in none of the four classes was a direct correl-
ation between the extent of STAT5 binding and the level
of gene expression.
We extended data analysis and included STAT5 binding
sites at genomic regions associated with gene body
and downstream sequences (+0.5 kb   +9kb) (Supple-
mentary Figure S4). We were unable to establish a direct
correlation between gene expression and STAT5 binding
strength.
DISCUSSION
Although it is well established that many cytokines
activate the transcription factor STAT5, evidence that
STAT5 binding controls cytokine-induced gene expression
is based on a reverse experimental designed. Uncovering
that expression of a given gene is regulated by cytokines
leads to the search for GAS motifs in the respective
promoter region and establishing in vitro and in vivo
STAT5 binding, followed by reporter gene experiments
Table 3. STAT5 binding and expression proﬁle in Class III genes (STAT5 binding in upstream regions independent of STAT5 concentration)
Name Max_peak_height Gene xpression
WT-GH WT-GH OE-GH OE-GH WT WT-GH OE OE-GH
Upstream Promoter Upstream Promoter
Hsp90aa1 43.9 0 156.8 0 2909 3218 2626 2978
Mapkapk3 149.3 0 120.7 27.2 892 1614 560 1317
Plec 75.6 63.9 96.7 0 6450 7335 7300 7900
Trim7 33.7 0 96.7 0 <100 <100 100 <100
Mtap4 45.9 0 87.8 16.2 4630 4536 5153 5344
Birc2 62.1 0 81 0 720 1324 879 931
Pds5a 37.7 0 81 0 142 160 185 298
0610040F04Rik 62.5 42.5 79.4 7.3 na
Necap1 48.1 0 79.4 6.3 2449 2307 2175 1915
Ptrf 45.3 0 76.3 0 3027 2913 2742 2447
Nnat 36.7 0 75.8 0 331 361 <100 <100
Snrpf 36.7 0 73.2 0 na
Pofut2 36.9 0 70 6.8 7222 6245 6491 7115
Sbno2 40.9 0 68.5 37.1 95 178 128 272
Stk11 40.9 23.4 68.5 12.5 345 445 580 764
Thy1 41.5 0 65.8 7.3 8465 7670 <100 <100
Ptgr2 46.9 0 65.8 0 1206 1050 1123 875
Lgals3 62.9 0 64.3 6.8 5029 5664 5246 6022
Zfp810 40.9 0 63.2 0 777 557 1209 1037
Atg16l2 51.5 0 61.7 18.3 149 177 368 484
Cln6 28.1 0 61.7 0 1616 1437 1946 1514
Dnaic2 21.8 0 61.1 0 <100 <100 <100 <100
Zfp36 32.3 0 59.6 20.4 954 1010 1228 620
Arhgap24 56.1 0 58.5 21.9 778 585 766 471
Afap1l2 39.7 0 58 12.5 217 245 <100 <100
Gja5 34.1 0 57.5 11 115 <100 <100 <100
Mpp1 75 0 56.4 18.8 1814 2076 2989 4150
Hcfc2 45.7 0 51.7 0 990 913 1173 1075
Trib3 95 0 50.7 31.9 1954 886 889 416
The peak height numbers refer to sequence tags and the gene expression numbers are relative expression levels provided by the Affymetrix software.
na, not available.
4468 Nucleic Acids Research, 2012,Vol.40, No. 10Table 4. STAT5 binding and expression proﬁle in Class IV genes (STAT5 binding in upstream regions only at elevated STAT5 concentration)
Name Max_peak_height Gene expression
WT-GH WT-GH OE-GH OE-GH WT WT-GH OE OE-GH
Upstream Promoter Upstream Promoter
Mir3091 0 0 144.2 0
Rps21 0 0 144.2 0 15214 15729 15247 14743
C130039O16Rik0 0 127 15.7 na
Zfp251 0 0 125.4 13.6 3423 3275 5425 5898
Zfp7 0 0 125.4 0 132 176 329 577
Adc 0 0 119.7 24 226 247 228 483
Eif2s2 0 0 119.7 8.9 8245 7973 6918 7112
Adamts5 0 0 118.6 4.2 5356 4007 5748 5027
St5 0 0 116 0 2865 2953 2493 2208
Themis 0 0 108.7 0 na
Gpd2 0 0 107.6 21.4 1064 1283 896 1905
Sumo3 0 7 100.8 0 5796 5748 5579 5039
Slc18a1 0 0 100.3 7.3 <100 <100 <100 <100
Zfr 0 0 100.3 6.3 6698 6307 7507 6736
Pdp1 0 0 98.8 8.9 na
2210012G02Rik 0 17.8 93 23 389 254 869 803
Speer7-ps1 0 0 89.3 14.6 <100 <100 603 584
Puf60 0 0 88.8 8.4 6338 6866 8408 8244
Il23a 0 0 88.3 0 <100 <100 <100 <100
Loxl2 0 0 87.3 0 6344 6737 <100 <100
Aebp2 0 0 86.7 16.2 3546 4429 3870 4164
Angptl2 0 0 86.7 0 4183 4202 5336 5405
Txnip 0 0 86.7 0 2182 1628 2912 1651
Chit1 0 0 86.2 0 <100 <100 <100 <100
Dock5 0 0 83.1 11 1452 1287 2106 2997
Zfp786 0 0 82 0 <100 <100 <100 <100
Snd1 0 19.2 81.5 19.3 2258 2411 2491 2180
Fam125a 0 0 81 0 1095 1274 2568 3098
Dennd1a 0 0 79.4 9.4 <100 <100 <100 <100
Cyb5d2 0 21 76.3 7.8 433 358 170 143
The peak height numbers refer to sequence tags and the gene expression numbers are relative expression levels provided by the Affymetrix software.
na, not available.
Figure 5. Correlation analysis between gene expression levels and STAT5 binding in MEFs upon GH induction. The level of gene expressions was
estimated from microarray analysis (y-axis). The degree of STAT5 bindings was calculated using maximum peak height in either promoter or
upstream regions according to the classiﬁcation (x-axis) (see ‘Materials and Methods’ section). Correlation was measured with Pearson’s correlation
coefﬁcient. Each spot indicates a single gene. (A) OE-GH. (B) WT-GH.
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onstrate the link between cytokine stimulation, transcrip-
tion factor binding and gene expression. However, it is not
clear how many genes that are recognized by STAT5 are
actually under STAT5 and cytokine control. We ad-
dressed this question by genome-wide identiﬁcation of
all genes that bind STAT5 and correlating their expression
at different STAT5 concentrations.
The GAS motif sequence TTCnnnGAA occurs statis-
tically once every 4096bp and therefore can be found in
the promoter/upstream sequence of virtually every single
gene. At physiological concentrations of STAT5,
GH-induced binding was observed at 13278 sites with
GAS motifs within the genome of MEFs. Using stringent
conditions, 78 genes featured STAT5 binding within 10kb
of promoter/upstream sequences. However, only four of
these genes (Socs2, Socs3, Cish and Bcl6) were soundly
under the control of GH by STAT5. A >20-fold
over-expression of STAT5A resulted in 71561 GH-
induced STAT5 binding peaks. Under stringent condi-
tions, 347 genes featured de novo STAT5 binding within
10kb of promoter/upstream sequences. Up to 15% of
these genes did not show any detectable basal or
GH-induced expression despite strong GH-induced
STAT5 binding. Out of the 234 expressed genes, only 4
acquired a modest (<2-fold) GH-induction upon STAT5
overexpression.
Analyzing genome-wide GH-induced STAT5 binding
and gene expression at different STAT5 concentrations
revealed novel information about the role of STAT5 as
a transcription factor. First, GH-induced STAT5 binding
intensity to regulatory regions in bona ﬁde STAT5 targets,
such as Socs2 and Cish is relatively concentration inde-
pendent. Thus, in these cases STAT5 is not a limiting
factor. However, GH-induced expression of both of
these genes increased in STAT5 overexpression. It is
possible, that the higher STAT5 concentration allows
binding over longer time windows. In contrast, regulation
of the bona ﬁde STAT5 target Bcl6 is independent of
STAT5 levels although additional binding sites within
the Bcl6 gene were uncovered upon STAT5
overexpression. Second, the majority of GH-induced
STAT5 binding in WT cells is associated with genes that
are expressed over a wide range but are not under GH
control. This ﬁnding demonstrates that STAT5 binding
to promoter upstream sequences does not automatically
convey STAT5 control over those genes. Third, increasing
STAT5 concentrations by at last 20-fold, which is
accompanied by GH-induced STAT5 phosphorylation,
greatly increases the number of genes bound by STAT5.
However, only a small fraction (18.6%, 30 out of 161) of
these genes acquired GH-STAT5 control (>1.5 fold).
Moreover, basal and GH-induced expression of a large
number of genes that acquire STAT5 binding is undetect-
able. This ﬁnding demonstrates that at elevated concen-
trations, STAT5 can bind to otherwise dormant GAS
motifs in promoter upstream sequences of both expressed
and silent genes. However, STAT5 binding is not sufﬁcient
to convey transcriptional activation. Fourth, although
STAT5 binding intensity to regulatory regions in bona
ﬁde target genes was mostly independent of the STAT5
concentration, STAT5 occupancy of a restricted set of
neighboring GAS motifs was observed in several genes,
including Socs3 and Bcl6. This demonstrates that depend-
ent on the concentration, STAT5 can also bind to
dormant sites within STAT5 target genes. However, this
binding appears to be of little or no consequence.
A similar discrepancy between transcription factor
binding and transcriptional regulation has been reported
for the ligand-induced glucocorticoid receptor (GR) (31).
More than 8200 GR binding sites were detected in a
mammary cell line but there was no clear association
with transcriptional regulation of nearby genes.
Of the STAT5 binding peaks,  50% coincide with GAS
motifs, conﬁrming the concept that STAT5 binds to
speciﬁc sequence motifs. However, the nature of STAT5
binding to sequences without bona ﬁde GAS motif is not
clear. We were unable to identify a unifying sequence
motif in non-canonical STAT5 binding areas. In
contrast, AP1 motifs were identiﬁed in canonical STAT5
binding areas at elevated STAT5 levels, suggesting
cooperativity between STAT5 and AP1.
ChIP-seq analyses have shed light onto binding
patterns of different STAT family members (8,9,30–33)
in several cell types. Dependent on the speciﬁc STAT
member and the investigating lab, each individual STAT
member binds to between several hundreds and >4000
genes. In many cases there is substantial overlap of
binding between different STATs members. For
example, out of the >4000 binding sites for STAT4,
50% were also targeted by STAT6 and vice versa (33).
The same seems to hold true for STAT3 and STAT5
(9). This observation is particularly relevant in light that
different STATs not only serve similar functions but
also can serve opposite functions. Although ChIP-seq
studies provide a detailed view on the genome-wide oc-
cupation by a given transcription factor, the biological
relevance of these ﬁndings remains to be determined.
Speciﬁcally, it is not clear why only a small fraction
of genes binding any given transcription factor appear
to be under its control. This enigma cannot be explained
by the lack of polymerase recruitment as many genes
binding STAT5 display already high basal activity.
Moreover, there were no apparent differences between
GAS motifs and neighboring sequences between pro-
ductive and non-productive sites. It is possible that
STAT5 is a weak transcription factor that has consid-
erable activity only in speciﬁc contexts.
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